Krystal Biotech, Inc. (KRYS) Misses Q2 EPS by 9c

Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q2 EPS of ($1.10), $0.09 worse than the analyst estimate of ($1.01).

For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
• Sharon AI surges premarket; New Oriental gains, Medline slips